164 related articles for article (PubMed ID: 38255931)
1. Function of Presynaptic Inhibitory Cannabinoid CB
Toczek M; Schlicker E; Remiszewski P; Malinowska B
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255931
[TBL] [Abstract][Full Text] [Related]
2. Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats.
Toczek M; Schlicker E; Grzęda E; Malinowska B
Life Sci; 2015 Oct; 138():78-85. PubMed ID: 25921770
[TBL] [Abstract][Full Text] [Related]
3. Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Harasim-Symbor E; Biernacki M; Kasacka I; Malinowska B
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063297
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
5. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
[TBL] [Abstract][Full Text] [Related]
6. Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve Analysis.
Toczek M; Ryszkiewicz P; Remiszewski P; Schlicker E; Krzyżewska A; Kozłowska H; Malinowska B
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446125
[TBL] [Abstract][Full Text] [Related]
7. Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.
Pędzińska-Betiuk A; Weresa J; Toczek M; Baranowska-Kuczko M; Kasacka I; Harasim-Symbor E; Malinowska B
Br J Pharmacol; 2017 Jul; 174(13):2114-2129. PubMed ID: 28437860
[TBL] [Abstract][Full Text] [Related]
8. Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration.
Biernacki M; Ambrożewicz E; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
Redox Biol; 2018 May; 15():41-50. PubMed ID: 29197803
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats.
Wheal AJ; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 2007 Nov; 152(5):717-24. PubMed ID: 17700721
[TBL] [Abstract][Full Text] [Related]
10. Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma.
Biernacki M; Malinowska B; Timoszuk M; Toczek M; Jastrząb A; Remiszewski P; Skrzydlewska E
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():54-63. PubMed ID: 30201316
[TBL] [Abstract][Full Text] [Related]
11. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634
[TBL] [Abstract][Full Text] [Related]
12. Differential endocannabinoid regulation of baroreflex-evoked sympathoinhibition in normotensive versus hypertensive rats.
Brozoski DT; Dean C; Hopp FA; Hillard CJ; Seagard JL
Auton Neurosci; 2009 Oct; 150(1-2):82-93. PubMed ID: 19464961
[TBL] [Abstract][Full Text] [Related]
13. Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus.
Grzeda E; Schlicker E; Luczaj W; Harasim E; Baranowska-Kuczko M; Malinowska B
J Physiol Pharmacol; 2015 Jun; 66(3):343-53. PubMed ID: 26084216
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
15. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.
Pfitzer T; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):9-17. PubMed ID: 15660243
[TBL] [Abstract][Full Text] [Related]
16. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
17. Cross-Talk between CB
Mińczuk K; Schlicker E; Malinowska B
Cells; 2022 May; 11(9):. PubMed ID: 35563848
[TBL] [Abstract][Full Text] [Related]
18. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model.
Anderson WB; Gould MJ; Torres RD; Mitchell VA; Vaughan CW
Neuropharmacology; 2014 Jun; 81():224-30. PubMed ID: 24384256
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
Bátkai S; Pacher P; Osei-Hyiaman D; Radaeva S; Liu J; Harvey-White J; Offertáler L; Mackie K; Rudd MA; Bukoski RD; Kunos G
Circulation; 2004 Oct; 110(14):1996-2002. PubMed ID: 15451779
[TBL] [Abstract][Full Text] [Related]
20. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
